医学信息2019，Vol.32Issue(3)：151-152,2.DOI:10.3969/j.issn.1006-1959.2019.03.049
厄贝沙坦氢氯噻嗪与福辛普利治疗原发性高血压的疗效观察
Efficacy of Irbesartan Hydrochlorothiazide and Fosinopril in the Treatment of Essential Hypertension
穆大明1
作者信息
- 1. 葫芦岛市第二人民医院心内科,辽宁 葫芦岛 125000
- 折叠
摘要
Abstract
Objective To investigate the effect of irbesartan hydrochlorothiazide in the treatment of essential hypertension.Methods 120 patients with essential hypertension admitted in our hospital from January to December 2017 were selected as study subjects.According to the random digital table method, they were divided into the control group and the experimental group two groups, 60 cases in each group.The control group was treated with fosinopril and the experimental group with irbesartan hydrochlorothiazide.The total effective rate, the improvement of blood pressure and the incidence of adverse reactions were observed.Results The total effective rate of the patients in the experimental group was 96.67％, which was better than that in the control group 75.00％;The incidence of adverse reactions in the experimental group was 5.00％, which was lower than that in the control group15.00％, the difference was statistically significant (P＜0.05) .Conclusion Irbesartan hydrochlorothiazide is effective and safe in the treatment of essential hypertension.It can be used as the first choice for the treatment of essential hypertension.关键词
厄贝沙坦氢氯噻嗪/福辛普利/原发性高血压/不良反应Key words
Irbesartan hydrochlorothiazide/Fosinopril/Essential hypertension/Adverse reactions分类
医药卫生引用本文复制引用
穆大明..厄贝沙坦氢氯噻嗪与福辛普利治疗原发性高血压的疗效观察[J].医学信息,2019,32(3):151-152,2.
